Lymphedema, a fluid buildup due to lymphatic system issues, commonly causes swelling in limbs. It often follows cancer treatments like surgery or radiation, disrupting lymph flow. Early detection ...

– Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patients – – Vision improvements were seen in ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from two Phase III studies evaluating the efficacy and safety of two doses of investigational vamikibart (0 ...

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...

Ottawa, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The global macular edema and macular degeneration market size was valued at USD 10.33 billion in 2024 and is predicted to hit around USD 22.51 billion by ...

ABSTRACT: Aim: This study aims to present a rare case of branch retinal vein occlusion (BRVO) that developed after cataract surgery and to evaluate possible preoperative and intraoperative risk ...

At the 131st Congress of the French Society of Ophthalmology in Paris, France, the role of second-generation intravitreal anti-VEGF injections compared to corticosteroid injections in treating ...

Cystoid macular edema (CME) is a common complication in various retinal disorders, often leading to significant central vision impairment. However, the underlying genetic causes and detailed clinical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Oral BI 1815368 from Boehringer Ingelheim aims to ...

Brain edema is a life-threatening condition where excess fluid causes the brain to swell. The primary medical treatment involves hyperosmolar agents like mannitol and hypertonic saline to draw fluid ...